Tamtam Try Tamtam free
Oscar Health logo

Oscar Health account plan

Revolutionizing health care through technology

At a glance

Oscar Health is a US ACA individual-market health insurer with 2,691,885 members and a $19.0-$19.3 billion 2026 revenue outlook.

Oscar Health, Inc. (NYSE: OSCR), founded in 2012, sells health insurance in the US ACA individual market to individuals, families and employees whose employers offer ICHRA (which Oscar calls CHOICE), on its own cloud-native technology platform. It now describes itself as "a leading consumer healthcare company" serving consumers, employers, brokers and partners through Oscar Insurance and its Marketplace Subsidiaries (Lucie, Trove Group and HealthInsurance.org). In FY2025 total revenue was $11,701,427 thousand with a net loss attributable to Oscar of $443,151 thousand; nine-month 2026 net income attributable to Oscar reached $1,208,085 thousand. It had about 2,305 employees at December 31, 2025 and 2,691,885 effectuated members at September 30, 2026, concentrated in Florida, Texas and Georgia.

Business units

Strategic priorities

Lead the individual market
Oscar's long-term vision is to build the consumer marketplace of the future and lead the individual market, with a target of 18% national ACA market share by 2029 and its TAM growing from 9.6 million to 16 million.
CHOICE (ICHRA) growth
Oscar wants to be the preferred carrier for employees enrolling through ICHRA; management sees half a million Choice lives in 2026 rising to 2.5 million by 2029.
Footprint expansion for 2027
A 24% larger footprint spanning 713 counties and entry into South Carolina, plus about 850,000 lives coming to market from competitor exits, support share gains in 2027 alongside a weighted average rate increase of about 14%.
AI-native operations
About two-thirds of production code is now written by coding agents, giving 2-3x faster time to market, and the Oswell AI agent resolves 30%-40% of member messages; the SG&A ratio reached a record-low 14% in Q3 2026.
Long-term financial targets
Oscar targets operating margin above 5% and EPS above $2.25 in 2027, and revenue CAGR above 20%, a 5%-7% operating margin and EPS above $4 by 2029.

Latest results

In Q3 2026 (quarter to September 30, 2026) total revenue rose to $5,139,298 thousand from $2,985,984 thousand, including a $250 million benefit from updated risk adjustment estimates. Earnings from operations were $178,018 thousand against a loss of $129,250 thousand, and net income attributable to Oscar was $167.3 million ($0.49 diluted EPS). The MLR improved to 84.0% from 88.5% on disciplined pricing and the SG&A ratio to 14.0% from 17.5%. Over nine months, net income attributable to Oscar was $1,208,085 thousand with an MLR of 78.1%. The FY2026 outlook was raised for a third time: total revenue $19.0-$19.3 billion, MLR 80.5%-81.5% and earnings from operations $850-$950 million.

Investments and deals

Marketplace acquisitions
In May 2025 Oscar acquired Lucie, IHC Specialty Benefits and Healthinsurance.org as building blocks of its ICHRA and consumer marketplace strategy.
Florida HMO subsidiary
Oscar contributed $500.0 million to Oscar Health Maintenance Organization of Florida, Inc., which began writing insurance in 2026.
Financing
Oscar issued $410.0 million of 2.25% convertible notes due 2030 in September 2025, exchanged most 2031 notes into stock, and signed a $475.0 million revolving credit facility on February 6, 2026, undrawn at September 30, 2026.
New products
Launches include RetireEase for early retirees, dental and vision bundles, an Allstate Health Solutions supplemental pairing, Hy-Vee Health with Oscar expanding to Nebraska, Missouri and Kansas, and HelloMeno off-exchange.

Challenges and risks

Expired enhanced subsidies
The enhanced APTCs expired at the end of 2025, which Oscar believes made coverage unaffordable for some individuals and reduced marketplace participation and its own membership since the end of the 2026 OEP.
Program integrity and enrollment friction
From October 12, 2026, EDE platforms must ID-proof certain consumers before brokers enroll them, and CMS eligibility reviews are removing members; Oscar expects about 2.5 million members at year-end.
Risk adjustment and morbidity estimates
Risk adjustment estimates rely on third-party data and swung FY2025 into a loss when the MLR rose to 87.4% from 81.7%.
Geographic and broker concentration
Membership is concentrated in Florida, Texas and Georgia, and distribution depends heavily on brokers.
Pharmaceutical tariffs
100% tariffs on patented pharmaceuticals from April 2, 2026 could make pharmaceutical rebates fall faster than drug costs, raising the MLR.

What leadership says

“Oscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time.”

Mark Bertolini, Chief Executive Officer · Q3 2026 results release, November 5, 2026

“The era of employer health insurance is ending”

Mark Bertolini, Chief Executive Officer · Investor Day 2026, September 16, 2026

“growing impact of AI that we are deploying across the business”

Scott Blackley, Chief Financial Officer · On Q3 SG&A, Q3 2026 earnings call, November 5, 2026

“Claims, service, clinical workflows, member experience. It's all the same codes, the same foundation, the same monorepo.”

Mario Schlosser, co-founder · Investor Day 2026, September 16, 2026

Where a supplier can help

Broker enablement and ID proofing
Tied to the program integrity challenge: tools that keep brokers productive under the new ID-proofing and eligibility rules support Lucie and Oscar's broker-led distribution.
Employer CHOICE adoption
Tied to the CHOICE growth priority: benefits platforms, payroll and HR partners that help employers move to ICHRA feed Oscar's target of 2.5 million Choice lives by 2029.
Expansion into new markets
Tied to the 2027 footprint expansion: provider network, marketing and member onboarding services for 713 counties and South Carolina support share gains.
Supplemental and consumer health products on Lucie
Tied to the Lucie Health Marketplace: carriers and supplemental product providers can reach brokers and consumers through a payer-agnostic platform.
Pharmacy and medical cost control
Tied to the risk adjustment and tariff challenges: pharmacy cost, claims review and data services address MLR pressure.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Oscar Health?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Oscar Health

What does Oscar Health do?

Oscar Health sells ACA individual-market health insurance to individuals, families and ICHRA employees on its own technology platform, and runs the Lucie Health Marketplace and brokerage businesses.

What is Oscar Health's revenue?

FY2025 total revenue was $11,701,427 thousand. For 2026 Oscar guides total revenue of $19.0-$19.3 billion, after nine-month revenue of $14,666,712 thousand.

How many members and employees does Oscar Health have?

Oscar had 2,691,885 effectuated members at September 30, 2026 and about 2,305 employees at December 31, 2025.

What is Oscar Health's strategy?

Oscar aims to lead the individual market, grow CHOICE (ICHRA) membership, expand its footprint, build Lucie into a consumer health marketplace and run as an AI-native carrier, targeting EPS above $4 by 2029.

Who leads Oscar Health?

Mark Bertolini is CEO, Scott Blackley is CFO, Janet Liang is President of Oscar Insurance and Mario Schlosser is co-founder.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)